Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases
Sign Up to like & getrecommendations! Published in 2021 at "Multiple Sclerosis and Related Disorders"
DOI: 10.1016/j.msard.2021.103189
Abstract: Background : The COVID-19 vaccines are currently recommended for people with rare neuroimmunological diseases such as Neuromyelitis optica spectrum disorder (NMOSD), MOG-antibody disease (MOGAD), and transverse myelitis. However, the safety profile of the vaccines in… read more here.
Keywords: vaccines persons; covid vaccines; safety; rare neuroimmunological ... See more keywords